000 01397 a2200385 4500
005 20250516164127.0
264 0 _c20131101
008 201311s 0 0 eng d
022 _a1555-2101
024 7 _a10.4088/JCP.12r08046
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReid, Jennifer G
245 0 0 _aLamotrigine in psychiatric disorders.
_h[electronic resource]
260 _bThe Journal of clinical psychiatry
_cJul 2013
300 _a675-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnticonvulsants
_xadministration & dosage
650 0 4 _aDepression
_xdrug therapy
650 0 4 _aDrug Approval
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xepidemiology
650 0 4 _aEpidemiologic Studies
650 0 4 _aHumans
650 0 4 _aLamotrigine
650 0 4 _aMedication Therapy Management
650 0 4 _aMental Disorders
_xdrug therapy
650 0 4 _aOff-Label Use
650 0 4 _aOutcome Assessment, Health Care
650 0 4 _aPrevalence
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTriazines
_xadministration & dosage
700 1 _aGitlin, Michael J
700 1 _aAltshuler, Lori L
773 0 _tThe Journal of clinical psychiatry
_gvol. 74
_gno. 7
_gp. 675-84
856 4 0 _uhttps://doi.org/10.4088/JCP.12r08046
_zAvailable from publisher's website
999 _c23004319
_d23004319